Octocog alfa, plasma/albumin-free method: profile report

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.22, Iss.6, 2006-06, pp. : 7-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Octocog alfa, Plasma/Albumin-Free Method

By McCormack Paul L. Plosker Greg L.

Drugs, Vol. 65, Iss. 18, 2005-01 ,pp. : 2613-2620

Adis International

Access to resources Recommend Favorite

Octocog alfa, Plasma/Albumin-Free Method: A Viewpoint by Massimo Franchini

By Franchini Massimo

Drugs, Vol. 65, Iss. 18, 2005-01 ,pp. : 2621-2622

Adis International

Access to resources Recommend Favorite

Octocog Alfa, Antihaemophilic Factor (Recombinant), Plasma/Albumin Free Method (Advate®): A Review of its Use in the Management of Patients with Haemophilia A

By Dhillon Sohita

Drugs, Vol. 72, Iss. 7, 2012-05 ,pp. : 987-1007

Adis International

Access to resources Recommend Favorite

Factor VIIIC/octocog alfa: Anaphylaxis: case report

Reactions Weekly, Vol. 1, Iss. 1144, 2007-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Economic and Epidemiological Modelling of Full-Length Antihaemophilic Factor (Recombinant), Plasma/Albumin-Free Method, in Previously Treated Patients with Haemophilia A: Comparison with B-Domain Deleted rFVIII, and Value of Potential Viral Transmission Reduction due to Plasma/Albumin-Free Status

By Sclar David A. Evans Marc A. Skaer Tracy L. Robison Linda M. Chung Karen C. Poulios Nick S.

Drugs in R&D, Vol. 6, Iss. 3, 2005-01 ,pp. : 149-156

Adis International

Access to resources Recommend Favorite